Topic: How To Invest

Wall Street Stock Forecaster Hotline – Friday, August 11, 2017

Article Excerpt

C.R. BARD INC., $319.75, New York symbol BCR, makes over 15,000 medical devices in four main areas: stents, catheters and other vascular products; oncology products that detect and treat various types of cancer; urology goods such as drainage and incontinence devices; and surgical tools. This week, shareholders voted to accept a takeover offer from rival medical-device maker Becton Dickinson & Co. (New York symbol BDX). Under the terms of the offer, Bard investors will receive $222.93 in cash plus 0.5077 of a Becton share for each BCR share they hold. That will give Bard shareholders a 15% stake in the new company. Based on Becton’s current share price, the offer is worth $324.65 per Bard share, which is 1.5% above Bard’s current price. It also represents a 28% rise over Bard’s share price just before Becton announced its bid. Today’s price indicates shareholders do not expect a higher offer. Becton and…